Both in Biotechnology
Ocugen vs X4 Pharmaceuticals
Over the past year OCGN returned −48.1% and XFOR returned −4.1%; their daily moves had a correlation of 0.19.
OCGN −48.1% XFOR −4.1%Growth of $1, one year, split-adjusted
| Metric | OCGN | XFOR |
|---|---|---|
| Price | $0.8151 | $3.01 |
| Market cap | $276.4M | $298.4M |
| Today | +0.32% | −0.33% |
| 1 month | −21.6% | −12.2% |
| 6 months | −51.5% | −31.9% |
| Year to date | −39.6% | −24.8% |
| 1 year | −49.7% | −4.1% |
| Revenue growth (YoY) | +8.4% | +346.3% |
| Gross margin | 100.0% | 81.6% |
| Net margin | −1671.8% | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 18.8× |
| Net cash | $15.9M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 66.0% |
| Short % of float | 31.5% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).